Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene-resistant PCOS: clomiphene + letrozole versus clomiphene + human gonadotropin
IRCT20211120053119N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clomiphene, letrozole and human chorionic gonadotropin in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Endometrial thickness, Pregnancy rate and 1 more. Started Dec 2021; status: completed.
02
Drugs
clomipheneletrozolehuman chorionic gonadotropin
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20211120053119N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211120053119N1.